Healthcare · head to head
PathAI vs Tebra

PathAI
Healthcare
Digital pathology image management with an FDA cleared platform for primary diagnosis
- From
- On request
- Rated
- -

Tebra
Healthcare
Practice management combining EHR, billing and patient engagement for independent practices
- From
- On request
- Rated
- -
The short version
- Each has a real cost: PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.; Tebra no pricing amounts published; custom quote required based on practice configuration
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which PathAI and Tebra actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), platforms (Web), user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in PathAI
- AISight image management
- AISight Dx
- Scanner interoperability
- Case and worklist management
- AI algorithm deployment
- Biopharmaceutical research tooling
- LIS integration
Only in Tebra
Nothing recorded that PathAI does not also cover.
What people use each for
The jobs each tool is most often brought in to do.
PathAI
- An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot Tebra
- A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot Tebra
- A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot Tebra
- A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot Tebra
Tebra
- Consolidating scheduling, charting, billing into single systemnot PathAI
- Automating claims submission and denial managementnot PathAI
- Reducing appointment no-shows through automated remindersnot PathAI
- Reducing documentation time to five minutes with AInot PathAI
- E-prescribing controlled substances with PDMP and EPCSnot PathAI
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
PathAI
- AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
- The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
- Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
- Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
- PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.
Tebra
- No pricing amounts published; custom quote required based on practice configuration
- Pricing based on per-provider licensing model with additional costs for EPCS setup and PDMP integration
Pricing, plan by plan
PathAI
On request- AISight$undefined/year
- Priced by annual slide or case volume and by pathologist seats
- AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
- Image storage priced by capacity and retention policy
Tebra
On requestNo published plan breakdown. See the Tebra review.
Which should you pick?
Choose Tebra if
Nothing in the data separates Tebra from PathAI on the points above - pick on price and on how each one feels to use.
Questions people ask
- Is PathAI or Tebra better?
- Neither clearly leads. PathAI starts at On request and Tebra at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, PathAI or Tebra?
- PathAI starts at On request and Tebra at On request.
- Does PathAI or Tebra run on more platforms?
- Both run on Web, so platform support will not decide this one for you.
- What is PathAI best used for?
- PathAI is most often used for an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version, a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location, a pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readers, a laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewer. Of those, an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version and a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location are not what Tebra is typically brought in for.
- What can PathAI do that Tebra cannot?
- PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management.
Answered from the vendors’ own pages
PathAI: What is the difference between AISight and AISight Dx?
AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.
Tebra: How does Tebra's pricing model work?
Pricing is based on the number of clinical providers rather than user seats. Non-clinical staff get unlimited access at no additional cost. Low-volume providers billing under 100 claims monthly receive lower-tier pricing.
SourcePathAI: Can we use our existing scanners?
Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.
Tebra: What are the setup and integration costs beyond the monthly fee?
Electronic Prescribing Controlled Substances (EPCS) setup costs approximately $75 per provider as a one-time fee. PDMP integration costs $500 one-time per facility plus approximately $50 per user per year.
SourcePathAI: Do the AI algorithms carry the same clearance as the platform?
No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.
Tebra: Are there volume discounts for practices using multiple modules?
Yes, bundled pricing and volume incentives are available for multi-module adoption. Practices can request a personalized quote to see potential savings.
SourcePathAI: Is pricing published?
No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.
Tebra: Does Tebra offer published pricing or is a quote always required?
Tebra does not publish specific monthly costs. Pricing varies depending on the number of providers, platform features needed, and implementation requirements. A personalized quote is required to get pricing.
SourceRelated pages
Other head to heads
- PathAI vs Techcyte
- PathAI vs Ambra Health
- PathAI vs Paige
- PathAI vs Sysmex
- PathAI vs Sectra
- PathAI vs Lunit
- PathAI vs Aidoc
- PathAI vs Ibex Medical Analytics
- PathAI vs Therapixel
- PathAI vs Gleamer
- PathAI vs Philips IntelliSpace PACS
- PathAI vs Annalise.ai
- PathAI vs Quantum Health
- PathAI vs TherapyNotes
- PathAI vs Zocdoc
- PathAI vs Allscripts Professional EHR
- PathAI vs Athenahealth
- PathAI vs Epic Systems
- PathAI vs Cerner
- PathAI vs Amwell
- PathAI vs ChiroTouch
- PathAI vs Dentrix
- PathAI vs RXNT
- PathAI vs Updox
- PathAI vs Kareo
- PathAI vs Healthie
- PathAI vs Bahmni
- PathAI vs Beckman Coulter DxONE
- PathAI vs Carestream Dental
- PathAI vs athenaOne
- PathAI vs Kareo Clinical
- PathAI vs Allscripts TouchWorks
- Tebra vs Techcyte
- Tebra vs Ambra Health
- Tebra vs Paige
- Tebra vs Sysmex
- Tebra vs Sectra
- Tebra vs Lunit
- Tebra vs Aidoc
- Tebra vs Ibex Medical Analytics
- Tebra vs Therapixel
- Tebra vs Gleamer
- Tebra vs Philips IntelliSpace PACS
- Tebra vs Annalise.ai
- Tebra vs Quantum Health
- Tebra vs TherapyNotes
- Tebra vs Zocdoc
- Tebra vs Allscripts Professional EHR
- Tebra vs Athenahealth
- Tebra vs Epic Systems
- Tebra vs Cerner
- Tebra vs Amwell
- Tebra vs ChiroTouch
- Tebra vs Dentrix
- Tebra vs RXNT
- Tebra vs Updox
- Tebra vs Kareo
- Tebra vs Healthie
- Tebra vs Bahmni
- Tebra vs Beckman Coulter DxONE
- Tebra vs Carestream Dental
- Tebra vs athenaOne
- Tebra vs Kareo Clinical
- Tebra vs Allscripts TouchWorks
